Ms Maryrose Malt
B.Bus
Data Manager
RECOVER Injury Research Centre
The University of Queensland
Level 7, Surgical Treatment and Rehabilitation Service
296 Herston Road
HERSTON QLD 4029
The University of Queensland
Level 7, Surgical Treatment and Rehabilitation Service
296 Herston Road
HERSTON QLD 4029
Maryrose has 20 years’ experience in the medical research field, in roles ranging from research assistant to project management. She has enjoyed contributing to a variety of longitudinal, single and multi-centre investigator-initiated studies into melanoma, pancreatic cancer, oesophageal cancer, and ovarian cancer.
Maryrose joined the RECOVER team in 2024 and will assist with the data management of various new research projects.
Journal Articles
Tan, Samuel X., Chong, Sharene, Rowe, Casey, Galbraith, Jack, Dight, James, Zhou, Chenhao, Malt, Maryrose, Smithers, Bernard Mark and Khosrotehrani, Kiarash (2024). Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma. Experimental Dermatology, 33 (3) e15041. doi: 10.1111/exd.15041
Burdett, Nikki L., Willis, Madelynne O., Pandey, Ahwan, Fereday, Sian, Bowtell, D., Chenevix-Trench, G., Green, A., Webb, P., DeFazio, A., Gertig, D., Traficante, N., Fereday, S., Moore, S., Hung, J., Harrap, K., Sadkowsky, T., Pandeya, N., Malt, M., Mellon, A., Robertson, R., Vanden Bergh, T., Jones, M., Mackenzie, P., Maidens, J., Nattress, K., Chiew, Y. E., Stenlake, A., Sullivan, H., Alexander, B. ... Clinical and Scientific Collaborators (2023). Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer. Scientific Reports, 13 (1) 21884. doi: 10.1038/s41598-023-48153-x
Tan, Samuel X., Chong, Sharene, Rowe, Casey, Claeson, Magdalena, Dight, James, Zhou, Chenhao, Rodero, Mathieu P., Malt, Maryrose, Smithers, B. Mark, Green, Adele C. and Khosrotehrani, Kiarash (2023). pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma. Melanoma Research, 33 (6), 506-513. doi: 10.1097/cmr.0000000000000915
Cook, Martin G., Grant, Megan, Sylvestre, Yvonne, Akhras, Victoria, Khosrotehrani, Kiarash, Hughes, Maria Celia B, Malt, Maryrose, Smithers, B. Mark, Massi, Daniela, De Giorgi, Vincenzo, Marais, Richard and Green, Adele C. (2023). Prognosis of naevoid melanomas. Pathology - Research and Practice, 251 154881, 154881. doi: 10.1016/j.prp.2023.154881
Tedman, Alexander James, Liyanage, Upekha E., Chong, Sharene, Rowe, Casey, von Schuckmann, Lena A., Malt, Maryrose, Green, Adele C., Smithers, B. Mark and Khosrotehrani, Kiarash (2023). Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal study. Australasian Journal of Dermatology, 64 (1), e34-e40. doi: 10.1111/ajd.13974
Hughes, M. C. B., Malt, M., Khosrotehrani, K., Smithers, B. M. and Green, A. C. (2022). Diet quality is associated with primary melanoma thickness. Journal of the European Academy of Dermatology and Venereology, 36 (10), 1745-1750. doi: 10.1111/jdv.18174
Ghiasvand, R., Khosrotehrani, K., Hughes, M.C.B., von Schuckmann, L. A., Beesley, V. L., Malt, M., Smithers, B. M. and Green, A. C. (2021). Patient age and risk of recurrence of primary melanoma at high risk of spread. British Journal of Dermatology, 184 (3) bjd.19601, 566-568. doi: 10.1111/bjd.19601
Green, Adele C., Hughes, Maria Celia B., Williams, Gail M., Malt, Maryrose, Beesley, Vanessa L., Khosrotehrani, Kiarash and Smithers, B. Mark (2021). Increased melanoma recurrence in patients with multiple primary invasive melanomas. Journal of the American Academy of Dermatology, 86 (6), 1366-1369. doi: 10.1016/j.jaad.2021.05.025
Kang, Eun Young, Cheasley, Dane, LePage, Cecile, Wakefield, Matthew J., da Cunha Torres, Michelle, Rowley, Simone, Salazar, Carolina, Xing, Zhongyue, Allan, Prue, Bowtell, David D. L., Mes-Masson, Anne-Marie, Provencher, Diane M., Rahimi, Kurosh, Kelemen, Linda E., Fasching, Peter A., Doherty, Jennifer A., Goodman, Marc T., Goode, Ellen L., Deen, Suha, Pharoah, Paul D. P., Brenton, James D., Sieh, Weiva, Mateoiu, Constantina, Sundfeldt, Karin, Cook, Linda S., Le, Nhu D., Anglesio, Michael S., Gilks, C. Blake, Huntsman, David G. ... Campbell, Ian G. (2021). Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology, 34 (1), 194-206. doi: 10.1038/s41379-020-0618-9
Beesley, Vanessa L., Hughes, Maria Celia B., Smithers, B. Mark, Khosrotehrani, Kiarash, Malt, Maryrose K., von Schuckmann, Lena A. and Green, Adèle C. (2020). Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal study. Journal of Cancer Survivorship, 14 (5), 712-719. doi: 10.1007/s11764-020-00885-9
von Schuckmann, Lena A., Khosrotehrani, Kiarash, Hughes, Maria Celia B., van der Pols, Jolieke C., Malt, Maryrose, Smithers, B. Mark and Green, Adele C. (2020). Prognostic implications of biopsy with tumor transection for patients with high-risk primary melanoma. Journal of the American Academy of Dermatology, 82 (6), 1521-1524. doi: 10.1016/j.jaad.2020.01.067
Mahamat-Saleh, Yahya, Hughes, Maria Celia B., Miura, Kyoko, Malt, Maryrose K., von Schuckmann, Lena, Khosrotehrani, Kiarash, Smithers, B. Mark and Green, Adèle C. (2020). Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at Diagnosis. Cancer Epidemiology Biomarkers & Prevention, 29 (8), 1647-1653. doi: 10.1158/1055-9965.epi-20-0319
Landi, Maria Teresa, GenoMEL Consortium, Bishop, D. Timothy, MacGregor, Stuart, Machiela, Mitchell J., Stratigos, Alexander J., Ghiorzo, Paola, Brossard, Myriam, Calista, Donato, Choi, Jiyeon, Fargnoli, Maria Concetta, Zhang, Tongwu, Rodolfo, Monica, Trower, Adam J., Menin, Chiara, Martinez, Jacobo, Hadjisavvas, Andreas, Song, Lei, Stefanaki, Irene, Scolyer, Richard, Yang, Rose, Goldstein, Alisa M., Potrony, Miriam, Kypreou, Katerina P., Pastorino, Lorenza, Queirolo, Paola, Pellegrini, Cristina, Cattaneo, Laura, Zawistowski, Matthew ... MelaNostrum Consortium (2020). Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nature Genetics, 52 (5), 494-504. doi: 10.1038/s41588-020-0611-8
von Schuckmann, L. A., Khosrotehrani, K., Ghiasvand, R., Hughes, M. C.B., van der Pols, J. C., Malt, M., Smithers, B. M. and Green, A. C. (2020). Statins may reduce disease recurrence in patients with ulcerated primary melanoma. British Journal of Dermatology, 183 (6), 1049-1055. doi: 10.1111/bjd.19012
Von Schuckmann, Lena A., Hughes, Maria Celia B., Ghiasvand, Reza, Malt, Maryrose, Van Der Pols, Jolieke C., Beesley, Vanessa L., Khosrotehrani, Kiarash, Smithers, B. Mark and Green, Adele C. (2019). Risk of melanoma recurrence after diagnosis of a high-risk primary tumor. JAMA Dermatology, 155 (6), 688-693. doi: 10.1001/jamadermatol.2019.0440
Kondrashova, Olga, Topp, Monique, Nesic, Ksenija, Lieschke, Elizabeth, Ho, Gwo-Yaw, Harrell, Maria I., Zapparoli, Giada V., Hadley, Alison, Holian, Robert, Boehm, Emma, Heong, Valerie, Sanij, Elaine, Pearson, Richard B., Krais, John J., Johnson, Neil, McNally, Orla, Ananda, Sumitra, Alsop, Kathryn, Hutt, Karla J., Kaufmann, Scott H., Lin, Kevin K., Harding, Thomas C., Traficante, Nadia, Chenevix-Trench, G., Green, A., Webb, P., Gertig, D., Fereday, S., Moore, S. ... Australian Ovarian Cancer Study (AOCS) (2018). Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma. Nature Communications, 9 (1) 3970. doi: 10.1038/s41467-018-05564-z
Moujaber, Tania, Etemadmoghadam, Dariush, Kennedy, Catherine J., Chiew, Yoke-Eng, Balleine, Rosemary L., Saunders, Catherine, Wain, Gerard V., Gao, Bo, Hogg, Russell, Srirangan, Sivatharsny, Kan, Casina, Fereday, Sian, Traficante, Nadia, Patch, Ann-Marie, Pearson, John V., Waddell, Nicola, Grimmond, Sean M., Dobrovic, Alexander, Bowtell, David D.L., Harnett, Paul R., deFazio, Anna, Bowtell, D., Chenevix-Trench, G., Green, A., Webb, P., DeFazio, A., Gertig, D., Traficante, N., Fereday, S. ... Zeps, N. (2018). BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition. JCO Precision Oncology, 2 (2), 1-14. doi: 10.1200/PO.17.00221
von Schuckmann, Lena A., Smith, David, Hughes, Maria Celia B., Malt, Maryrose, van der Pols, Jolieke C., Khosrotehrani, Kiarash, Smithers, Bernard M. and Green, Adele C. (2017). Associations of statins and diabetes with diagnosis of ulcerated cutaneous melanoma. Journal of Investigative Dermatology, 137 (12), 2599-2605. doi: 10.1016/j.jid.2017.07.836
Rowe, Casey J., Tang, Fiona, Hughes, Maria Celia B., Rodero, Mathieu P., Malt, Maryrose, Lambie, Duncan, Barbour, Andrew, Hayward, Nicholas K., Smithers, B. Mark, Green, Adele C. and Khosrotehrani, Kiarash (2016). Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma. International Journal of Cancer, 139 (3), 664-672. doi: 10.1002/ijc.30085
Smithers, B.Mark, Hughes, Maria Celia B., Beesley, Vanessa L., Barbour, Andrew P., Malt, Maryrose K., Weedon, David, Zonta, Mark J., Wood, Dominic J., Triscott, Joseph A., Bayley, Gerard J., Brown, Lee J., Allan, Christopher P., D'Arcy, Justin, Williamson, Richard, Khosrotehrani, Kiarash and Green, Adele C. (2015). Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia. Journal of Surgical Oncology, 112 (4), 359-365. doi: 10.1002/jso.24013
Beesley, Vanessa L., Smithers, B. Mark, Khosrotehrani, Kiarash, Khatun, Modsina, O'Rourke, Peter, Hughes, Maria Celia B., Malt, Maryrose K., Zonta, Mark J., Bayley, Gerard J., Barbour, Andrew P., Brown, Lee J., D'Arcy, Justin, Allan, Christopher and Green, Adèle C. (2014). Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia. Psycho-Oncology, 24 (7), 763-770. doi: 10.1002/pon.3718
Conference Papers
Chong, S., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2019). Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell.
Chong, S., Rowe, C., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2019). SOX18 activation in primary melanoma tumours. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell.
Chong, S., Green, A., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2018). Effect of a previous diagnosis of primary invasive melanoma on the progression of subsequent primary invasive melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.17_12815
Rowe, C., Tang, F., Hughes, M. C., Rodero, M., Malt, M., Lambie, D., Barbour, A., Hayward, N., Smithers, B. M., Green, A. and Khosrotehrani, K. (2016). Prognostic value of nomograms incorporating biomarkers vs. sentinel node status in patients with stage IB and II melanoma. Australasian College of Dermatologists 49th Annual Scientific Meeting, Perth, Australia, 14–17 May, 2016. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12480
Rowe, C., Tang, F., Rodero, M., Malt, M., Lambie, D., Smithers, M., Green, A. and Khosrotehrani, K. (2015). Immune cell infiltrate subtypes inform on melanoma survival in stage Ib and II melanomas. Australasian College of Dermatologists 48th Annual Scientific Meeting, Adelaide, Australia, 16 May 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337
Rowe, C. J., Rodero, M., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2013). Pilot multi-marker analysis to evaluate prognosis in stage Ib and II melanomas. The Australasian College of Dermatologists 46th Annual Scientific Meeting, Sydney, NSW Australia, 19 – 22 May 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12051
Rodero, M., Wright, A., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2012). Activation of stat5 is an indicator of good prognosis in stage Ib and II melanomas. The Australasian College of Dermatologists 45th Annual Scientific Meeting, Brisbane, QLD, Australia, 20-23 May 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-0960.2012.00892.x